|Systematic (IUPAC) name|
|Mol. mass||166.20 g/mol|
|Metabolism||75% by CYP enzymes|
|Half life||9–18 hours|
|Excretion||20% excreted as glucuronide|
Sodium valproate (INN) or valproate sodium (USAN) is the sodium salt of valproic acid and is an anticonvulsant used in the treatment of epilepsy and bipolar disorder, as well as other psychiatric conditions requiring the administration of a mood stabilizer. The intravenous formulations are used when oral administration is not possible.
Trade names are in bold, followed by the manufacturer.
- Intravenous injection – Depacon by Abbott Laboratories.
- Syrup – Depakene by Abbott Laboratories. (Note Depakene capsules are valproic acid).
UK and Australia
- Tablets – Orlept by Wockhardt and Epilim by Sanofi-Aventis.
- Oral solution – Orlept Sugar Free by Wockhardt and Epilim by Sanofi-Aventis.
- Syrup – Epilim by Sanofi-Aventis.
- Intravenous injection – Epilim Intravenous by Sanofi-Aventis.
- Extended release tablets – Epilim Chrono by Sanofi-Aventis. A combination of sodium valproate and valproic acid in a 2.3:1 ratio.
- Enteric-coated tablets – Epilim EC200 by Sanofi-synthélabo. A 200 mg sodium valproate enteric-coated tablet.
Germany, Switzerland, Norway
- Tablets – Orfiril by Desitin Pharmaceuticals
- Intravenous injection – Orfiril IV by Desitin Pharmaceuticals
- Syrup – Convulex by Byk Madaus
- Intravenous injection – Epival or Epiject by Abbott Laboratories.
- Syrup – Depakene by Abbott Laboratories. Generic formulations include Apo-Valproic and ratio-Valproic.
In much of Europe, Depakine and Depakine Chrono are equivalent to Epilim and Epilim Chrono above.
- Chemical Land21: Sodium Valproate
- RXList.com: Depacon (Sodium Valproate)
- British National Formulary Edition 50
- Med Broadcast.com: Epival
- Drugs.com: Depaken Syrup
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies